Drug Profile
Interleukin-6 - Yeda
Alternative Names: IL-6; r-hIL6; Recombinant human interleukin-6; Sigosix®; SJ0031; β2-interferonLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Yeda
- Class Antineoplastics; Interleukins
- Mechanism of Action Natural killer cell stimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Haematological disorders; Haematological malignancies; Preleukaemia; Thrombocytopenia
Most Recent Events
- 01 Mar 2000 Suspended-I for Cancer in USA (Unknown route)
- 01 Mar 2000 Suspended-II for Cancer in European Union (Unknown route)
- 01 Mar 2000 Suspended-II for Cancer in Japan (Unknown route)